Aclarion Inc
For the period ended Jun 30, 2024. Filed Aug 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 14, 2024
ACON$1.75+5.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Cash Flows
| Six Months Ended June 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities | ||
| Net income (loss) | $(3,637,180) | $(2,648,017) |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Depreciation and amortization | 90,864 | 79,809 |
| Share-based compensation | 156,131 | 219,162 |
| Loss on exchange of debt | 1,066,732 | – |
| Loss on extinguishment of debt | 111,928 | – |
| Amortization of deferred issuance costs | 442,289 | 28,520 |
| Change in fair value related to warrants and derivative | (323,041) | 11,800 |
| Non-cash interest related to bridge funding | 49,116 | 14,346 |
| Change in assets and liabilities | ||
| Accounts receivable | (5,115) | 1,414 |
| Prepaids and other current assets | (405,657) | 33,287 |
| Accounts payable | (540,710) | 57,914 |
| Accrued and other liabilities | (267,325) | 241,110 |
| Note payable, net of discount | (31,129) | – |
| Net cash (used in) operations | (3,293,096) | (1,960,653) |
| Investing activities | ||
| Intangible assets - Patents | (157,523) | (72,634) |
| Net cash (used in) investing activities | (157,523) | (72,634) |
| Financing activities | ||
| Issuance of common stock and warrants related to public offering, net deductions | 2,691,391 | – |
| Proceeds from equity line | 1,754,032 | – |
| Repayment of promissory notes | (300,973) | – |
| Equity line cash issuance costs | (262,744) | – |
| Public offering cash issuance costs | (256,094) | – |
| Bridge fund cash issuance costs | (23,375) | (85,000) |
| Proceeds from bridge funding | – | 1,250,000 |
| Proceeds from sale of Series A preferred stock | – | 1,000 |
| Redemption of Series A Preferred stock | – | (1,000) |
| Net cash provided by financing activities | 3,602,237 | 1,165,000 |
| Net increase (decrease) in cash and cash equivalents | 151,618 | (868,287) |
| Cash, cash equivalents and restricted cash, beginning of period | 1,031,069 | 1,482,806 |
| Cash, cash equivalents and restricted cash, end of period | $1,182,687 | $614,518 |
| Non-cash activities | ||
| Issuance of common shares in exchange for debt | 1,519,779 | – |
| Issuance of bridge fund commitment shares | 33,297 | 175,619 |
| Fair value of warrants and derivative related to bridge funding | – | 742,988 |
| Accrued debt issuance costs related to bridge funding | – | 118,575 |
| Issuance of warrants related to bridge funding | – | 37,500 |
| Original issue discount (15%) related to bridge funding | – | 187,500 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.